REAL-WORLD DATA (RWD) / REAL-WORD EVIDENCE (RWE) INSIGHTS
-
Is Double Programming Really Required For Validation?
Double programming has been the gold standard for validation, but technological advancements and improved sponsor oversight of CRO deliverables have introduced more efficient and reliable alternatives.
-
Meaningful Industry Change Means Balancing Tech And Human Touch
Technology and AI/ML are advancing at an unprecedented pace, and we must not lose sight of our industry's core: human-to-human interaction.
RWD/RWE RESOURCES
-
ISPOR 2024-2025 Top 10 HEOR Trends
This report outlines ten defining HEOR trends influencing global health decision-making.
-
One Day, Clinical Trials Will Represent The Real World
What needs to happen for RWE to reach its full regulatory potential? We discussed this with industry leaders during the One Day Summit, and here are some key takeaways.
-
Mental Health Apps: Regulation And Validation Are Needed
Explore a proposed digital ecosystem that would balance rigorous validation with the urgent need for accessible mental health solutions, transforming the landscape into a resource for global well-being.
-
How Medidata Link Is Supporting Moderna's Clinical Trial Real-World Data Linkage Initiatives
Discover how Medidata Link empowers Moderna's clinical trial RWD linkage initiatives, enhancing insights into treatment outcomes while minimizing administrative burdens.
-
Connecting Patient-Level Clinical Data To RWD
Discover data linkage: a cutting-edge innovation that unlocks a new frontier of enhanced evidence generation by linking clinical trial data and real world data at the patient level.
-
Keep Up With These 5 Patient Engagement And Recruitment Trends
From decentralized trials to real world data, take a look at top trends, their impact on patient enrollment and more, as well as ways to stay ahead of the curve.
-
8 Key Applications Of Real-World Data In Multiple Myeloma Therapy Development
Explore how therapeutic area (TA) datasets can be leveraged to address the challenges multiple myeloma (MM) presents in the field of hematologic malignancies.